United States Vaccines Market Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 112
Inquire Before Buying

In this report, the United States Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Vaccines in these regions, from 2012 to 2022 (forecast).

United States Vaccines market competition by top manufacturers/players, with Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- GSK

- Sanofi

- Merck

- Pfizer

- Novartis(GSK)

- CSL

- MedImmune

- J&J(Crucell)

- China National Biotec

- Tiantan

- Hualan

- Kangtai

- Hissen

- Jintan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Recombinant Vaccines

- Viral Vaccines

- Polysaccharide Vaccines

- Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Vaccines for each application, including

- Adult

- Children

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Vaccines Market Report 2017

Table of Contents
United States Vaccines Market Report 2017
1 Vaccines Overview
1.1 Product Overview and Scope of Vaccines
1.2 Classification of Vaccines by Product Category
1.2.1 United States Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Recombinant Vaccines
1.2.4 Viral Vaccines
1.2.5 Polysaccharide Vaccines
1.2.6 Other
1.3 United States Vaccines Market by Application/End Users
1.3.1 United States Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Adult
1.3.3 Children
1.4 United States Vaccines Market by Region
1.4.1 United States Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Vaccines Status and Prospect (2012-2022)
1.4.3 Southwest Vaccines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Vaccines Status and Prospect (2012-2022)
1.4.5 New England Vaccines Status and Prospect (2012-2022)
1.4.6 The South Vaccines Status and Prospect (2012-2022)
1.4.7 The Midwest Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Vaccines (2012-2022)
1.5.1 United States Vaccines Sales and Growth Rate (2012-2022)
1.5.2 United States Vaccines Revenue and Growth Rate (2012-2022)
2 United States Vaccines Market Competition by Players/Suppliers
2.1 United States Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Vaccines Market Competitive Situation and Trends
2.4.1 United States Vaccines Market Concentration Rate
2.4.2 United States Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Vaccines Manufacturing Base Distribution, Sales Area, Product Type
3 United States Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Vaccines Price by Region (2012-2017)
4 United States Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Vaccines Price by Type (2012-2017)
4.4 United States Vaccines Sales Growth Rate by Type (2012-2017)
5 United States Vaccines Sales (Volume) by Application (2012-2017)
5.1 United States Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Vaccines Players/Suppliers Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Vaccines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.2 Vaccines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.2 Vaccines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Vaccines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis(GSK)
6.5.2 Vaccines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 CSL
6.6.2 Vaccines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 MedImmune
6.7.2 Vaccines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 MedImmune Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 J&J(Crucell)
6.8.2 Vaccines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 China National Biotec
6.9.2 Vaccines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Tiantan
6.10.2 Vaccines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Hualan
6.12 Kangtai
6.13 Hissen
6.14 Jintan
7 Vaccines Manufacturing Cost Analysis
7.1 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Vaccines
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Vaccines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Vaccines Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Vaccines
Figure United States Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Recombinant Vaccines Product Picture
Figure Viral Vaccines Product Picture
Figure Polysaccharide Vaccines Product Picture
Figure Other Product Picture
Figure United States Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Vaccines by Application in 2016
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Vaccines Sales Share by Players/Suppliers
Figure United States Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Vaccines Revenue Share by Players/Suppliers
Table United States Market Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Vaccines Product Category
Table United States Vaccines Sales (K Units) by Region (2012-2017)
Table United States Vaccines Sales Share by Region (2012-2017)
Figure United States Vaccines Sales Share by Region (2012-2017)
Figure United States Vaccines Sales Market Share by Region in 2016
Table United States Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Vaccines Revenue Share by Region (2012-2017)
Figure United States Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Vaccines Revenue Market Share by Region in 2016
Table United States Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Vaccines Sales (K Units) by Type (2012-2017)
Table United States Vaccines Sales Share by Type (2012-2017)
Figure United States Vaccines Sales Share by Type (2012-2017)
Figure United States Vaccines Sales Market Share by Type in 2016
Table United States Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vaccines by Type (2012-2017)
Figure Revenue Market Share of Vaccines by Type in 2016
Table United States Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Vaccines Sales (K Units) by Application (2012-2017)
Table United States Vaccines Sales Market Share by Application (2012-2017)
Figure United States Vaccines Sales Market Share by Application (2012-2017)
Figure United States Vaccines Sales Market Share by Application in 2016
Table United States Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Vaccines Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Vaccines Sales Growth Rate (2012-2017)
Figure GSK Vaccines Sales Market Share in United States (2012-2017)
Figure GSK Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Vaccines Sales Growth Rate (2012-2017)
Figure Merck Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Vaccines Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer Vaccines Sales Market Share in United States (2012-2017)
Figure Pfizer Vaccines Revenue Market Share in United States (2012-2017)
Table Novartis(GSK) Basic Information List
Table Novartis(GSK) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis(GSK) Vaccines Sales Growth Rate (2012-2017)
Figure Novartis(GSK) Vaccines Sales Market Share in United States (2012-2017)
Figure Novartis(GSK) Vaccines Revenue Market Share in United States (2012-2017)
Table CSL Basic Information List
Table CSL Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Vaccines Sales Growth Rate (2012-2017)
Figure CSL Vaccines Sales Market Share in United States (2012-2017)
Figure CSL Vaccines Revenue Market Share in United States (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MedImmune Vaccines Sales Growth Rate (2012-2017)
Figure MedImmune Vaccines Sales Market Share in United States (2012-2017)
Figure MedImmune Vaccines Revenue Market Share in United States (2012-2017)
Table J&J(Crucell) Basic Information List
Table J&J(Crucell) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure J&J(Crucell) Vaccines Sales Growth Rate (2012-2017)
Figure J&J(Crucell) Vaccines Sales Market Share in United States (2012-2017)
Figure J&J(Crucell) Vaccines Revenue Market Share in United States (2012-2017)
Table China National Biotec Basic Information List
Table China National Biotec Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure China National Biotec Vaccines Sales Growth Rate (2012-2017)
Figure China National Biotec Vaccines Sales Market Share in United States (2012-2017)
Figure China National Biotec Vaccines Revenue Market Share in United States (2012-2017)
Table Tiantan Basic Information List
Table Tiantan Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tiantan Vaccines Sales Growth Rate (2012-2017)
Figure Tiantan Vaccines Sales Market Share in United States (2012-2017)
Figure Tiantan Vaccines Revenue Market Share in United States (2012-2017)
Table Hualan Basic Information List
Table Kangtai Basic Information List
Table Hissen Basic Information List
Table Jintan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccines
Figure Manufacturing Process Analysis of Vaccines
Figure Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Vaccines
Table Distributors/Traders List
Figure United States Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • 2017-2022 China Cetirizine Hydrochloride Market Report (Status and Outlook)
    Published: 21-Nov-2017        Price: US 3360 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include - UCB Pharma - Pfizer - J & J - Mylan - Teva - HUAPONT Pharm - Hunan Jiudian Pharm - Sun Pharma - Lunan Pharma ......
  • 2017-2022 Europe Top Countries Cetirizine Hydrochloride Market Report
    Published: 21-Nov-2017        Price: US 4660 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Europe Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses on the top players in each country, covering......
  • 2017-2022 Global Top Countries Cetirizine Hydrochloride Market Report
    Published: 21-Nov-2017        Price: US 4960 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the global Cetirizine Hydrochloride market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle E......
  • Global Phenylketonuria (PKU) Market Professional Survey Report 2017
    Published: 21-Nov-2017        Price: US 3500 Onwards        Pages: 103
    This report studies Phenylketonuria (PKU) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Biomarin(US) - Vitaflo(UK) - Mead Johnson(US) - Nutricia(US)......
  • 2017-2022 India Cetirizine Hydrochloride Market Report (Status and Outlook)
    Published: 21-Nov-2017        Price: US 3360 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India market, the top players include - UCB Pharma - Pfizer - J & J - Mylan - Teva - HUAPONT Pharm - Hunan Jiudian Pharm - Sun Pharma - Lunan Pharm......
  • China Epinephrine Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 21-Nov-2017        Price: US 4480 Onwards        Pages: 118
    Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.......
  • 2017-2022 North America Cetirizine Hydrochloride Market Report
    Published: 21-Nov-2017        Price: US 4660 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the North America Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering - UCB Pharma - Pfizer......
  • 2017-2022 United States Cetirizine Hydrochloride Market Report (Status and Outlook)
    Published: 21-Nov-2017        Price: US 3360 Onwards        Pages: 128
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Cetirizine Hydrochloride market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the top players include - UCB Pharma - Pfizer - J & J - Mylan - Teva - HUAPONT Pharm - Hunan Jiudian Pharm - Sun Pharma......
  • Global Cystic Fibrosis Drugs Market Professional Survey Report 2017
    Published: 21-Nov-2017        Price: US 3500 Onwards        Pages: 125
    This report studies Cystic Fibrosis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Actavis - F. Hoffmann-La Roche - Gilead Sciences - Novartis......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs